Photocure ASA
PHCUF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$152.67M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $152.67 Million |
|---|---|
| Enterprise Value | $-351,683.00 |
| Earnings per Share | $-0.06 |
| Beta | 0.35 |
| Outstanding Shares | 27,021,649 |
Return
| Return on Equity | 8.00% |
|---|---|
| Return on Assets | 5.39% |
| Return on Invested Capital | 23.40% |
Valuation & Multiples
| P/E Ratio | 25.19 |
|---|---|
| PEG | -3.32 |
| Price to Sales | 0.23 |
| Price to Book Ratio | 0.26 |
| Enterprise Value to Revenue | 1.6 |
| Enterprise Value to EBIT | 5.86 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 28, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$14.65 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 24, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$15.97 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Photocure ASA
101 employees
CEO: Daniel Schneider
Photocure ASA operates as a specialized pharmaceutical company, managing the entire lifecycle of pharmaceutical products from initial research and development through to their manufacturing, distribution, marketing, and commercialization...